iodine I 131 monoclonal antibody CC49-deltaCH2
Term · Oncology and biomedicine · MLC-T-ONC-014530
A radioimmunoconjugate consisting of the humanized CH2 domain-deleted monoclonal antibody CC49 and iodine I 131 with antineoplastic activity. Monoclonal antibody CC49-deltaCH2 targets the tumor-associated glycoprotein 72 (TAG-72) that is expressed by a wide range of human neoplasms including colorectal, gastric, pancreatic, ovarian, endometrial, breast, non-small cell lung, and prostate cancers. Iodine I 131 monoclonal antibody CC49-deltaCH2 binds to tumor cells expressing TAG-72, selectively delivering a cytotoxic dose of beta and gamma radiation.
| Identifier | MLC-T-ONC-014530 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 131I-MOAB CC49-deltaCH2 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014530",
"term": "iodine I 131 monoclonal antibody CC49-deltaCH2",
"field": "Oncology and biomedicine",
"definition": "A radioimmunoconjugate consisting of the humanized CH2 domain-deleted monoclonal antibody CC49 and iodine I 131 with antineoplastic activity. Monoclonal antibody CC49-deltaCH2 targets the tumor-associated glycoprotein 72 (TAG-72) that is expressed by a wide range of human neoplasms including colorectal, gastric, pancreatic, ovarian, endometrial, breast, non-small cell lung, and prostate cancers. Iodine I 131 monoclonal antibody CC49-deltaCH2 binds to tumor cells expressing TAG-72, selectively delivering a cytotoxic dose of beta and gamma radiation.",
"abbreviation": "131I-MOAB CC49-deltaCH2",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/iodine-i-131-monoclonal-antibody-cc49-deltach2/"
}
Record 9,511 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.